Bivalirudin for Injection 250 mg (Bivalirudin POWDER FOR SOLUTION) 250 MG

Bivalirudin for Injection 250 mg is a powder for solution used for intravenous administration. This medication is commonly associated with anticoagulant therapy, helping to prevent blood clots. It is manufactured by Fresenius Kabi Canada Ltd.

Strength

250 MG

Pack Size

5ML

Manufacturer / TM Owner

FRESENIUS KABI CANADA LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Bivalirudin is primarily used as an anticoagulant to prevent blood clots during certain medical procedures. It is often administered intravenously to manage clotting risks in patients undergoing procedures like angioplasty or other cardiovascular interventions. The medication works by inhibiting the action of thrombin, a key enzyme in the blood clotting process.

Side Effects

Common effects of Bivalirudin may include bleeding at the injection site or prolonged bleeding times. Patients may also experience bruising or redness around the injection area. These effects are generally mild and temporary, but any persistent or severe reactions should be discussed with a healthcare provider.

Precautions & Warnings

Bivalirudin should be handled with care to avoid contamination. It is important to follow proper administration procedures to minimize the risk of bleeding. Patients with a history of bleeding disorders or those taking other anticoagulants should use this medication under medical supervision.

Avoid Interactions

Bivalirudin may interact with other anticoagulants, antiplatelet drugs, and nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should be avoided as it can increase the risk of bleeding. Always inform your healthcare provider about all medications and supplements you are taking.

References

Frequently Asked Questions

Bivalirudin is used as an anticoagulant to prevent blood clots during medical procedures, particularly those involving the cardiovascular system.

Bivalirudin is administered intravenously as a powder for solution. It should be prepared and administered by a healthcare professional.

Common side effects include bleeding at the injection site, bruising, and prolonged bleeding times. Severe reactions are rare but should be reported to a healthcare provider.

Bivalirudin may interact with other anticoagulants, antiplatelet drugs, and NSAIDs. Always consult a healthcare provider before combining medications.

Patients with a history of bleeding disorders or those taking other anticoagulants should use Bivalirudin with caution and under medical supervision.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.